BioSpace News Archive

Cereno Scientific announced that the company has expanded its global footprint by establishing a subsidiary with new office space located in Kendall Square at the Cambridge Innovation Center, Cambridge, Boston, Massachusetts.

ICON plc, a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the UBS Virtual Global Healthcare Conference on Wednesday, May 20, 2020.

CMAB completed a full scope development and manufacturing project for Q-1802 in 9 months for dual IND filing in China and the US Completion of the project demonstrates the significant speed to clinic achievable with CMAB’s fully integrated development and manufacturing platform QureBio’s bispecific antibody Q-1802 will enter clinical trials to assess treatment of solid tumors s

Ascletis Pharma Inc. (HKEX code: 1672) announces today that it received IND approval from China’s National Medical Products Administration (NMPA) for its in-house developed Category 1 Drug ASC41 to conduct clinical trials for Non-alcoholic Steatohepatitis (NASH) indication. Ascletis has two additional drug

- Company on track to provide multiple data readouts for XLRP and ACHM clinical programs in 2H 2020 - - Company on track for End of Phase 2 meeting in Q2 2020 - - Company sees minimal COVID-19 impact to date - - Company to host conference call and webcast today at 8:00am ET - GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 13, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated vi

A new mail-in blood test for children with transplanted organs eliminates the need for vulnerable immunosuppressed patients to visit the hospital to have blood drawn in person.

The global blood cell analyzer market depicts a highly competitive and expansive vendor landscape to exist, says Transparency Market Research on the basis of a recently published report.

Next Generation Sequencing or NGS is an outstanding technology that arranges massive DNA strands through enormous parallelization.

Natural killer cells are generally big granular lymphocytes. These cells react quickly to any pathological problem.

Further Solidifies Merck Animal Health’s Position in the U.S. Companion Animal Category with Comprehensive, Continuous Parasite Protection